SC 13G

Company

Chemomab Therapeutics Ltd.

Filed

January 2, 2020

Accession Number

0000905718-20-000006

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →